Amplia Therapeutics (INNMF) Financial Statements
Amplia Therapeutics Financial Overview
Amplia Therapeutics's market cap is currently $30.31M. The company's EPS TTM is $-0.02; its P/E ratio is -5.03; Amplia Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 3.78M | $ 4.45M | $ 1.19M | $ 1.98M |
| Gross Profit | $ -92.14K | $ 3.57M | $ 4.01M | $ 1.12M | $ 1.98M |
| Operating Income | $ -13.18M | $ -6.52M | $ -4.42M | $ -7.48M | $ -3.64M |
| EBITDA | $ -13.09M | $ -6.71M | $ -4.48M | $ -7.26M | $ -3.64M |
| Net Income | $ -7.71M | $ -6.57M | $ -4.50M | $ -6.24M | $ -3.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 27.85M | $ 10.86M | $ 3.39M | $ 9.26M | $ 14.61M |
| Total Assets | $ 41.44M | $ 22.94M | $ 14.85M | $ 18.68M | $ 24.48M |
| Total Debt | $ 341.11K | $ 13.89K | $ 1.59M | $ 2.27M | $ 2.10M |
| Net Debt | $ -27.51M | $ -10.85M | $ -1.80M | $ -6.99M | $ -12.51M |
| Total Liabilities | $ 1.97M | $ 1.91M | $ 3.43M | $ 2.85M | $ 2.64M |
| Stockholders' Equity | $ 39.47M | $ 21.02M | $ 11.42M | $ 15.84M | $ 21.85M |
| Cash Flow | |||||
| Free Cash Flow | $ -8.77M | $ -6.89M | $ -5.13M | $ -5.31M | $ -4.42M |
| Operating Cash Flow | $ -8.73M | $ -6.89M | $ -5.13M | $ -5.29M | $ -4.40M |
| Investing Cash Flow | $ -96.22K | $ -2.07K | $ -2.23K | $ -58.42K | $ -26.64K |
| Financing Cash Flow | $ 25.94M | $ 14.32M | $ -772.98K | $ -84.22K | $ 17.19M |
Currency in AUD